Skip to main content
. Author manuscript; available in PMC: 2020 Jan 29.
Published in final edited form as: Org Biomol Chem. 2020 Jan 22;18(3):405–408. doi: 10.1039/c9ob02666e

Table 1. Identification of the best-suited SCF3-transfer reagent, catalyst and conditions for the synthesis of 2aa.


Inline graphic
Entry Cat. (mol%) [CF3S]+ (eq.) Solv. Base (eq.) Yieldb [%] e.r.c (S : R)d

1 A2 (5) I (3) Et2O Cs2CO3 (2) 80 82 : 18
2 A2 (5) II (3) Et2O Cs2CO3 (1.1) 70 75 : 25
3 A2 (5) III (3) Et2O Cs2CO3 (1.1) 0
4 A2 (5) IV (3) Et2O Cs2CO3 (1.1) 0
5 A1 (5) I (1.5) Et2O Cs2CO3 (1.1) 77 90 : 10
6 A1 (5) I (1.2) Et2O K2CO3 (0.2) 89 89 : 11
7 A1 (5) I (1.2) iPr2O K2CO3 (0.2) 85 87 : 13
8 A1 (5) I (1.2) THF K2CO3 (0.2) 66 76 : 24
9 A1 (5) I (1.2) CH2Cl2 K2CO3 (0.2) 53 75 : 25
10 A1 (5) I (1.2) PhCH3 K2CO3 (0.2) 56 84 : 16
11 A1 (5) I (1.2) Et2O KOAc (0.2) 25 90 : 10
12 A1 (5) I (1.2) Et2O NaOPh (0.2) 71 89 : 11
13 A1 (5) I (1.2) Et2O K2HPO4 (0.2) 88 90 : 10
14 A1 (5) I (1.05) Et2Oe K2HPO4 (0.2) 82 91 : 9
15f A1 (5) I (1.05) Et2Oe K2HPO4 (0.2) 90 93 : 7 (98 : 2)g
16f A1 (5) I (1.05)h Et2Oe K2HPO4 (0.2) 90 95 : 5
17f,i A1 (3) I (1.05) Et2Oe K2HPO4 (0.2) 90 93 : 7
a

All reactions were run for 20 h at room temperature using 0.1 mmol 1a in the indicated solvent (0.1 M with respect to 1a) with the given reagents and catalysts unless otherwise stated.

b

Isolated yields.

c

Determined by HPLC using a chiral stationary phase.

d

Absolute configuration was determined by X-ray diffraction analysis of single crystals of enantioenriched (S)-2a.21

e

0.05 M with respect to 1a.

f

Run at –20 °C.

g

After recrystallization.

h

Added with a syringe pump over 5 h.

i

1 mmol scale.